Detalhe da pesquisa
1.
Making the case for EGFR TKI sequencing in EGFR mutation-positive NSCLC: a GioTag study US patient analysis.
Future Oncol;
16(22): 1585-1595, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32757853
2.
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: final analysis of the GioTag study.
Future Oncol;
16(34): 2799-2808, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32854536
3.
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: updated analysis of the observational GioTag study.
Future Oncol;
15(25): 2905-2914, 2019 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31370698
4.
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study.
Future Oncol;
14(27): 2861-2874, 2018 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30336693
5.
Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
Am J Ther;
23(1): e321-3, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24451298
6.
HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management.
Clin Lung Cancer;
25(2): 159-167, 2024 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38158315
7.
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).
J Clin Oncol;
42(5): 562-570, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37988638
8.
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer.
Clin Transl Radiat Oncol;
41: 100643, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37346274
9.
Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort.
Cancers (Basel);
13(6)2021 Mar 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33806774
10.
Who Benefits the Most From Adjuvant Durvalumab After Chemoradiotherapy for Non-small Cell Lung Cancer? An Exploratory Analysis.
Pract Radiat Oncol;
11(2): e172-e179, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33127337
11.
First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer.
Lung Cancer;
154: 99-104, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33636454
12.
Impact of Primary Care Access on Mortality of Lung Cancer Patients in an Underserved Community.
Am J Clin Oncol;
42(3): 298-303, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30663997
13.
Positron Emission Tomography-Adjusted Intensity Modulated Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys;
102(4): 709-715, 2018 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29249527
14.
Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
Clin Lung Cancer;
19(5): e767-e773, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29937386
15.
Secondhand Smoke Exposure Among Community-Dwelling Adult Cancer Survivors in the United States: 1999-2012.
Cancer Epidemiol Biomarkers Prev;
26(8): 1296-1305, 2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28642231
16.
Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer.
Clin Lung Cancer;
18(1): 60-67, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27919627
17.
Evolving Concepts: Immunity in Oncology from Targets to Treatments.
J Oncol;
2015: 847383, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26060497
18.
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer.
Lung Cancer;
87(1): 23-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25468149
19.
Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma.
Clin Lung Cancer;
20(3): e242-e246, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30665873
20.
Denosumab for treatment of hypercalcemia of malignancy.
J Clin Endocrinol Metab;
99(9): 3144-52, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24915117